Vor Ort
Merkzettel Warenkorb
Produktbild: Human Papillomavirus

Human Papillomavirus Proving and Using a Viral Cause for Cancer

111,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.11.2019

Herausgeber

David Jenkins + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

460

Maße (L/B/H)

23,4/19/2,2 cm

Gewicht

907 g

Sprache

Englisch

ISBN

978-0-12-814457-2

Beschreibung

Portrait

Senior Researcher. Practitioner and author and Emeritus Professor in Pathology, University of Nottingham, UKSenior Consultant to the Cancer Epidemiology Research Program and Director of International Affairs at the Catatan Institute of Oncology - Director of the e-oncologia - Co-Director of the the IARC / ICO Information Centre on HPV and Cancer, Catalan Institute of OncologyCancer Epidemiology Research ProgramGranvia de L'Hospitalet 199-20308908 L'Hospitalet de Llobregat (Barcelona, Catalonia, Spain)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.11.2019

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

460

Maße (L/B/H)

23,4/19/2,2 cm

Gewicht

907 g

Sprache

Englisch

ISBN

978-0-12-814457-2

EU-Ansprechpartner

Kolibri 360 GmbH
Ettore-Bugatti-Straße 6-14
51149 Köln
DE
produktsicherheit@kolibri360.de

Herstelleradresse

Elsevier Science & Technology
125 London Wall
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Human Papillomavirus

  • Section 1: Early questions and their slow answers
    1. Introduction: Implications and responses to a possible specific infectious cause for a solid cancer, approaches to proving the role of HPV, and exploring its potential uses against conventional medical practice
    2. Cervical and other cancers now associated with HPV prior to recognition of HPV in cervical cancer
    3. Cervical screening and its basis in ideas of precancer in classical microscopic pathology
    4. The "discovery" of HPV I6 in cervical cancer and studies of its transforming role, P53 and pRB
    5. Growing numbers of carcinogenic papillomaviruses and understanding of their differences
    6. The impact of HPV on conventional morphological pathology of cancer and precancer. Bethesda classification, molecular markers relating morphology to molecular mechanisms
    7. The proof of causality in humans
    8. Progression from infection to cancer
    9. Sexuality and HPV: sexual transmission, male role
    10. Genital warts
    11. HPV and non-cervical cancer
    12. Immune responses, and antibodies to HPV, making viral antigens
    13. Developing and standardising HPV tests
    14. HPV and non-HPV pathways to cancer

    Section 2: Prevention of cancer and HPV infection
    15. Introduction: Evidence-based medicine, HPV and cancer prevention
    16. Triage of women with low-grade smear abnormalities and HPV testing, HC1 and 2, GP5+/6+, ALTS trial, Netherlands, other trials
    17. Primary screening by HPV testing
    18. Prophylactic vaccines, proving their value and the role and limitations of the pharmaceutical industry and its regulators, safety and efficacy
    19. Modelling disease, prevention and cost-effectiveness - a developing process, different types of models, what does cost-effectiveness mean?
    20. Changing global concerns about screening and vaccination